{"entity":{"id":"fukuda-haruhiko","kind":"person","name":"Haruhiko Fukuda","aka":[],"tldr":"Built the data centre behind the Japan Clinical Oncology Group, the country's main academic trials network.","summary":"Haruhiko Fukuda is the founding director of the JCOG Data Center at the National Cancer Center in Tokyo and a clinical trial methodologist. He established and long led the data centre behind the Japan Clinical Oncology Group, the country's main academic trials network, setting the methodological standards for its cooperative-group surgical, radiotherapy and chemotherapy trials in gastric, oesophageal, lung and other cancers. His publications include the JCOG0802 trial of segmentectomy against lobectomy in small peripheral non-small-cell lung cancer, the JCOG1013 trial of docetaxel added to cisplatin and S-1 in advanced gastric cancer, and the JCOG0603 trial of hepatectomy followed by mFOLFOX6 in liver-only metastatic colorectal cancer. His interests are trial methodology and biostatistics.","asOf":"2026-09-08","links":[{"label":"JCOG","url":"https://jcog.jp/en/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Fukuda%20H%5BAuthor%5D%20JCOG"}],"tags":[],"related":[],"cancers":["gastric","esophageal","nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["jcog"],"institutions":["ncc-japan"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Founding director of the JCOG Data Center (National Cancer Center); clinical trial methodologist","institutionId":"jcog","specialisms":["Clinical trial methodology","Biostatistics","Cooperative group trials"],"profiles":[{"label":"JCOG","url":"https://jcog.jp/en/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Fukuda%20H%5BAuthor%5D%20JCOG"}],"papers":[{"title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","journal":"The Lancet","year":2022,"doi":"10.1016/s0140-6736(21)02333-3"},{"title":"Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial","journal":"The Lancet Gastroenterology & Hepatology","year":2019,"doi":"10.1016/s2468-1253(19)30083-4"},{"title":"Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial","journal":"Journal of Clinical Oncology","year":2021,"doi":"10.1200/jco.21.01032"}],"orcid":"0000-0002-6332-4745"},"route":"/people/fukuda-haruhiko/","neighbours":{"cancer":[{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"}],"company":[{"id":"jcog","kind":"company","name":"Japan Clinical Oncology Group (JCOG)","route":"/companies/jcog/"}],"institution":[{"id":"ncc-japan","kind":"institution","name":"National Cancer Center Hospital","route":"/institutions/ncc-japan/"}]}}